ALLMedicine™ Movement Disorders Center

May 20th, 2022 - Objective: The primary objective of this study is to perform phenotypic and genotypic characterizations of patients and family members with a known or suspected diagnosis of a movement disorder and screen for eligibility to participate in other mo...

May 20th, 2022 - Objectives: The study investigates the neurobiological correlates of conversion disorder (CD). The primary objectives are to investigate in CD patients: The role of emotional valence in an implicit emotional processing task (COMPLETE) The frequenc...

May 18th, 2022 - Seizures are a very common manifestation of autoimmune encephalitis (AE), ranging from 33% to 100% depending on the antigen, most often accompanied by other clinical features such as behavioral changes, movement disorders, memory deficits, autoimm...

May 17th, 2022 - Aromatic L-amino acid decarboxylase deficiency (AADCd) is an ultra-rare genetic neurometabolic disorder caused by mutations in the DDC gene. This retrospective, noninterventional study was designed to describe the burden of AADCd including the ass...

May 17th, 2022 - Functional movement disorder (FMD) is a type of functional neurological disorder (FND) characterized by abnormal movements that patients do not perceive as self-generated. Prior imaging studies show a complex pattern of altered activity, linking r...

Dec 30th, 2020 - Most patients with movement disorders have speech impairments resulting from sensorimotor abnormalities that affect phonatory, articulatory, and prosodic speech subsystems. There is widespread cross-discipline use of speech recordings for diagnost...

May 7th, 2020 - Movement disorders and neurodegenerative diseases are a variety of conditions that involve progressive neuronal degeneration, injury, or death. Establishing the correct diagnosis of a movement disorder or neurodegenerative process can be difficult...

Jan 15th, 2008 - Dementia and movement disorders.|2008|Dormont D,Seidenwurm DJ, , ,|classification,complications,diagnosis,standards,classification,complications,diagnosis,

May 20th, 2022 - Objective: The primary objective of this study is to perform phenotypic and genotypic characterizations of patients and family members with a known or suspected diagnosis of a movement disorder and screen for eligibility to participate in other mo...

May 20th, 2022 - Objectives: The study investigates the neurobiological correlates of conversion disorder (CD). The primary objectives are to investigate in CD patients: The role of emotional valence in an implicit emotional processing task (COMPLETE) The frequenc...

May 2nd, 2022 - Handwriting is a complex cognitive prowess that deteriorates in patients affected by neurodegenerative diseases, including movement disorders. More in detail, patients with Parkinson's disease (PD) may manifest prominent handwriting abnormalities ...

Apr 29th, 2022 - The pathophysiological mechanisms underlying Movement Disorders, including Parkinson's disease, have been related to altered synaptic plasticity affecting several structures of the central nervous system. Although several previous neurophysiologic...

Apr 29th, 2022 - The study had three stages. In the first stage, a wide range of investigatory pulse shapes in a small number of patients. The effect of the pulses on the therapeutic window will be assessed. Stage 2 will perform a short-term chronic evaluation in ...

May 19th, 2022 - This transcript has been edited for clarity. Kathrin LaFaver, MD: Hello, and welcome to Medscape. Today we'll be discussing highlights in movement disorders from the recent American Academy of Neurology (AAN) annual meeting. I have the great pleas...

May 18th, 2022 - This transcript has been edited for clarity. Andrew N. Wilner, MD: Welcome to Medscape. I'm your host, Dr Andrew Wilner. Today, I am interviewing Dr Christopher Gibbons about his research presented at this year's American Academy of Neurology meet...

Mar 24th, 2022 - This transcript has been edited for clarity. Kathrin LaFaver, MD: Welcome to Medscape Neurology. I'm Dr Kathrin LaFaver, a neurologist and movement disorder specialist in Saratoga Springs, New York. I have the pleasure today of speaking with Dr In...

Feb 9th, 2022 - Dairy intake may increase risk of Parkinson's disease in men, according to investigators. Men of European ancestry with a genetic marker predicting dairy consumption had significantly greater risk of Parkinson's disease than individuals without th...

Nov 12th, 2021 - A 1-mg daily dose of rasagiline has no disease-modifying effect for patients with Parkinson's disease (PD), new research confirms. Results from a randomized, double-blind, placebo-controlled trial support previous observations that free-water accu...